Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains
Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains MarketWatch
Covered in this story
Analyst targets on Amgen
- RBC Capital Markets: $406 → $430 by Oct 2027 via Pluang
- Cantor Fitzgerald: $406 → $440 by Oct 2027 via AD HOC NEWS
- Truist Securities: $413 → $380 by Oct 2027 · Hold via Investing.com Canada
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AMGN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Amgen →Dalsna Finance is currently tracking 47 stories mentioning Amgen, the earliest published 5 Aug 2026.
Summary aggregated from MarketWatch's public RSS feed. The full reporting belongs to MarketWatch — please read it on their site.